Active Research Trials
PRECISE
Precision Approaches to Lung Cancer Screening and Smoking Cessation Treatment in Primary Care
- Annual lung cancer screening and tobacco treatment are pillars of cancer prevention and control yet are often not provided by physicians or received by patients in primary care settings.
- New evidence suggests that personalized risk feedback including a patient’s genetic and clinical information could highlight the benefits of these practices and engage physicians and patients in improved care.
- This study will test the impact of a genetically-informed intervention on physicians’ ordering and patients’ completion of lung cancer screening and tobacco treatment in primary care.
For more information about this study, please visit:
MOTIVATE
A Multi-level Intervention to Personalize and Improve Tobacco Treatment in Primary Care
- Smoking is a leading cause of premature death, causing more than half of all cancer deaths. However, tobacco treatment is often not provided and not highly effective in primary care.
- New evidence suggests that a precision treatment approach to motivate and guide treatment based on personal genetic and metabolic markers could improve treatment uptake and quit success.
- This study will test the impact of a multilevel precision treatment intervention on improving tobacco treatment and health outcomes in primary care.
For more information about this study, please visit:
Recent
Findings
Smoking Cessation Resources
CONTACT US
PRECISE Trial
behaviorandgenetics@email.wustl.edu
314-747-7849
MOTIVATE Trial
motivate@email.wustl.edu
314-273-3826